Skip to main content

Help the Network and win an IPOD

Later this year the HPS Network will launch our first capital campaign. Many not-for-profits have annual capital campaigns to help raise money for operating costs. You’ve more than likely received letters in the mail with a particular charity’s story and an appeal for donations.

To have an effective campaign, we are currently developing a fundraising database – a collection of names and addresses of people who might be interested in making a donation, however modest, to the HPS Network. And, we’re appealing to you for help with this process.

The people most likely to be interested in helping our efforts to find treatments, and one day the cure, for HPS are those closest to us – our grandparents, uncles, aunts, cousins, friends and even our doctors.

We’re asking our HPS community to send in the names and addresses of their contacts that they think would be good to add to our database. Then, most likely around Thanksgiving, those contacts will receive an appeal letter from the HPS Network asking for their help. You supply the names and addresses – we’ll do the rest.

As an incentive, we’re holding a drawing for an IPOD (model not yet known). For every five names you submit, you’ll be entered in the drawing once. Thus, for example, if you send in 20 names and addresses, you’ll get four chances to win.

If you want to enter the drawing, please send in your names and addresses either all at once, or in batches of five. Entries can be e-mailed to Donna Appell at:
hpsnet@worldnet.att.net, or you can mail your entries to: Hermansky-Pudlak Syndrome Network Inc. One South Road Oyster Bay, New York 11771-1905.

P.S. You don't have to be an HPS'er to help with this project! Feel free to enter!

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria